| Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France T Lequerré, P Quartier, D Rosellini, F Alaoui, M De Bandt, O Mejjad, ... Annals of the rheumatic diseases 67 (3), 302-308, 2008 | 460 | 2008 |
| COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study J Avouac, E Drumez, E Hachulla, R Seror, S Georgin-Lavialle, ... The Lancet Rheumatology 3 (6), e419-e426, 2021 | 259 | 2021 |
| Non–TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical trial JE Gottenberg, O Brocq, A Perdriger, S Lassoued, JM Berthelot, ... Jama 316 (11), 1172-1180, 2016 | 219 | 2016 |
| Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a … M Dougados, M Soubrier, E Perrodeau, L Gossec, F Fayet, M Gilson, ... Annals of the Rheumatic Diseases 74 (9), 1725-1733, 2015 | 173 | 2015 |
| Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label … B Fautrel, T Pham, T Alfaiate, F Gandjbakhch, V Foltz, J Morel, E Dernis, ... Annals of the rheumatic diseases 75 (1), 59-67, 2016 | 171 | 2016 |
| The familial form of spondylarthropathy: a clinical study of 115 multiplex families R Said‐Nahal, C Miceli‐Richard, JM Berthelot, A Duché, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 157 | 2000 |
| New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases D Wendling, J Paccou, JM Berthelot, RM Flipo, S Guillaume-Czitrom, ... Seminars in arthritis and rheumatism 41 (3), 503-510, 2011 | 154 | 2011 |
| Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey R Seror, C Richez, C Sordet, S Rist, L Gossec, G Direz, E Houvenagel, ... Rheumatology 52 (5), 868-874, 2013 | 151 | 2013 |
| Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease. A nationwide series É Toussirot, É Houvenagel, V Goëb, D Fouache, A Martin, P Le Dantec, ... Joint Bone Spine 79 (5), 457-463, 2012 | 130 | 2012 |
| Infectious sacroiliitis: a retrospective, multicentre study of 39 adults M Hermet, E Minichiello, RM Flipo, JJ Dubost, Y Allanore, JM Ziza, ... BMC infectious diseases 12, 1-7, 2012 | 125 | 2012 |
| Recommendations of the French Society for Rheumatology regarding TNFα antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update T Pham, B Fautrel, E Dernis, P Goupille, F Guillemin, X Le Loët, P Ravaud, ... Joint Bone Spine 74 (6), 638-646, 2007 | 119 | 2007 |
| Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort GC Alegria, D Guellec, X Mariette, JE Gottenberg, E Dernis, JJ Dubost, ... RMD open 2 (1), e000179, 2016 | 112 | 2016 |
| Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs--comparison of drugs and adverse reactions. PS Helliwell, WJ Taylor, CASPAR Study Group The Journal of Rheumatology 35 (3), 472-476, 2008 | 104 | 2008 |
| Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial R Felten, V Devauchelle-Pensec, R Seror, P Duffau, D Saadoun, ... Annals of the rheumatic diseases 80 (3), 329-338, 2021 | 101 | 2021 |
| Safety and efficacy of anti–tumor necrosis factor α therapy in ten patients with recent‐onset refractory reactive arthritis A Meyer, E Chatelus, D Wendling, JM Berthelot, E Dernis, E Houvenagel, ... Arthritis & Rheumatism 63 (5), 1274-1280, 2011 | 97 | 2011 |
| Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries C Gorlier, AM Orbai, D Puyraimond-Zemmour, LC Coates, U Kiltz, ... Annals of the rheumatic diseases 78 (2), 201-208, 2019 | 91 | 2019 |
| A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren’s syndrome M Jasiek, A Karras, V Le Guern, E Krastinova, R Mesbah, S Faguer, ... Rheumatology 56 (3), 362-370, 2017 | 89 | 2017 |
| Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trial. JS Giraudet-Le Quintrec, A Mayoux-Benhamou, P Ravaud, K Champion, ... The Journal of rheumatology 34 (8), 1684-1691, 2007 | 88 | 2007 |
| Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial A Molto, C López-Medina, FE Van den Bosch, A Boonen, C Webers, ... Annals of the Rheumatic Diseases 80 (11), 1436-1444, 2021 | 86 | 2021 |
| Influence of patient education on exercise compliance in rheumatoid arthritis: a prospective 12-month randomized controlled trial. A Mayoux-Benhamou, JS Giraudet-Le Quintrec, P Ravaud, K Champion, ... The Journal of rheumatology 35 (2), 216-223, 2008 | 85 | 2008 |
